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Abstract 
Rutin, a polyphenolic natural compound is described in the literature for a wide range of biological activities. The study aims 
to test the antiproliferative potential and the antibacterial effect for pure rutin and its β cyclodextrin complexes. On one hand, 
the antiproliferative assays against A2780 (human ovarian cells), MDA-MB-231 (human breast cancer cells) and SiHa 
(cervical cancer cells) did not show any substantial inhibition of cell growth. On the other hand, the antimicrobial screening 
revealed that rutin presents positive effects against: Streptococcus pyogenes, Enterococcus faecalis, Bacillus cereus, Pseudomonas 
aeruginosa, Klebsiella pneumoniae and Escherichia coli. A decreased, but detectable, activity was noticed for Staphylococcus 
aureus and Streptococcus pneumoniae. Incorporation in the ramified cyclodextrins had a mixed effect on the antibacterial 
activity, with increased, constant or decreased effect, depending on the strain. The study concludes that rutin can be re-
considerate as a natural active antibacterial agent, while modulation of its solubility by incorporation in β-cyclodextrins is 
debatable depending on the tested strain. 
 
Rezumat 
Rutozida este un compus natural cu structură de tip polifenol, descris în literatură pentru o gamă largă de activități biologice. 
Studiul present și-a propus să testeze potențialul antiproliferativ și efectul antibacterian pentru rutozida pură, respectiv după 
încorporare în trei tipuri de β ciclodextrine. Pe de o parte testele antiproliferative pe liniile celulare A2780 (celule de cancer 
ovarin), MDA-MB-231 (celule de cancer de sân) și SiHa (celule de cancer de de col uterin) nu au evidențiat nici o inhibare 
substanțială a creșterii celulare.Pe de altă parte evaluarea antimicrobiană arată că rutozida a prezentat un efect pozitiv împotriva 
următoarelor tulpini: Streptococcus pyogenes, Enterococcus faecalis, Bacillus cereus, Pseudomonas aeruginosa, Klebsiella 
pneumoniae și Escherichia coli. O activitate scăzută, dar detectabilă, a fost observată pentru Staphylococcus aureus și Streptococcus 
pneumoniae. Incorporarea în ciclodextrine ramificate a avut un efect mixt asupra activității antibacteriene, cu efect crescut, 
constant sau scăzut, în funcție de tulpină. Studiul concluzionează că rutozida poate fi reconsiderată ca agent antibacterian 
natural. Modularea solubilității prin încorporarea în ciclodextrinele β ramificate este discutabilă în funcție de tulpina testate. 
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Introduction 
Rutin is a glycosylated polyphenolic phytocompound 
which is widespread in coloured fruits and vegetables. 
Medicinal plants with high rutin content include: 
buckwheat (Fagopyrum esculentum Moench) [17], 
elderberry (Sambucus nigra L.) [13], japanese pagoda 
tree (Sophora japonica L) [19] and herb-of-grace 
(Ruta graveolens L.) [22]. 
The phytocompound was assigned with pleiotropic 
pharmacological effects (e.g.): capability to increase 
capillary resistance and decrease capillary permeability 
[15]; antiplatelet aggregatory effects [9, 10]; important 
antiinflammatory effects by inhibiting NO, TNF-α 
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and MPO activity in activated human neutrophils 
[23] as well the synthesis of pro-inflammatory 
cytokines, TNF-α and NF-kB in inflammatory bowel 
disease [35]. Rutin exhibited powerful antioxidant 
activity by counteracting the reactive oxygen 
species (ROS) both in vitro [43] and in vivo [11] 
and was demonstrated to have an antiproliferative 
and proapoptotic activity against different cancer 
cell lines including: GL-15 human glioblastoma, 
A549 human lung, MCF-7 breast, HepG2 liver and 
HT-29 colon cancer cells [33, 42, 44]. Finally, rutin 
has shown antibacterial and antifungal activity as 
well as synergistic effects against methicillin 
resistant S. aureus (MRSA), when co-administered 
with classic antibiotics [1]. Moreover, the phyto-
compound was able to reduce the toxicity and 
improve antifungal activity of Amphotericin B 
when tested against Cryptococcus sp. [25]. Despite 
the multiple pharmacological effects and its 
therapeutic potential, rutin exhibits a poor water 
solubility, thus affecting it’s in vivo bioavailability. 
For this purpose, many formulation strategies were 
conducted in order to improve this downside. One 
of these strategies is represented by encapsulating 
the flavonoid in cyclodextrins (CDs). CDs are cyclic 
oligosaccharides made up of α-D-glucopyranoside 
units, exhibiting a hydrophobic profile on the inside 
and a hydrophilic one on the outside of the 
glycosidic ring. Thereby, these features make CDs 
potential drug delivery systems for hydrophobic 
molecules in order to increase their bioavailability. 
Various studies were conducted in order to assess 
the advantages of CD encapsulation for different 
types of molecules [12, 36]. In a previous study, 
several flavonols (fisetin, quercetin and kaempferol) 
encapsulated in β-CDs showed promising anti-
proliferative activity vs. native compounds when 
tested on A2780 human ovarian carcinoma, MDA-
MB-231 human breast cancer and SiHa human 
cervix cancer cells [6]. Other types of molecules, 
such as nerolidol, a component of essential oils, was 
investigated after encapsulation in α-CD, β-CD, γ-CD, 
HP-β-CD, RAMEB (randomly methylated-beta-
cyclodextrins), CRYSMEB (methylated beta-cyclo-
dextrin) and SBE-β-CD (sulfobutylether-β-cyclodextrin) 
highlighting their effectiveness as encapsulating agents 
and solubility enhancers [2]. Also, pentacyclic tri-
terpenes such as betulin esters, ursolic and oleanolic 
acids complexes with CDs showed increased in vitro 
antiproliferative activity when tested on human 
melanoma cell lines [26, 30, 31]. All these promising 
results make this formulation strategy a powerful 
tool in improving the bioavailability and increasing 
the effectiveness of hydrophobic phytocompounds 
with important therapeutic potential. 
In the present study, our aim was to investigate 
native rutin compared to its inclusion complex in 
CDs regarding: i) the antiproliferative activity on 
three tumour cell lines (A2780 human ovarian cancer, 
MDA-MB-231 human breast cancer and SiHa cervical 
cancer) and ii) the antibacterial activity against different 
bacterial strains (S. pyogenes, E. faecalis, B. cereus, 
P. aeruginosa, K. pneumoniae and E. coli).  
 
Materials and Methods 
Reagents 
Reagents were purchased as follows: rutin from Sigma 
Aldrich, Germany, β-cyclodextrin (BCD), hydroxyl-
propyl-β-cyclodextrin (HPBCD) and randomly 
methylated β-cyclodextrin (RAMEB) from Cyclolab, 
Hungary.  
Complexes preparation  
For the development of the inclusion complexes the 
kneading method was used as described in the papers 
of Danciu et al, [6, 7]. All the complexes were 
prepared using a molar ration 1:2 active substance: 
CD (MwRutin = 610.52 g/mol, MwBCD = 1134.98 g/mol, 
MwHPBCD = 1396 g/mol, MwRAMEB = 1312 g/mol).  
Cell culture 
All three gynaecological cancer cell lines, namely: 
A2780 (human ovarian), MDA-MB-231 (human breast) 
and SiHa (cervical) (ECACC-European Collection of 
Cell Cultures, Salisbury, UK) were cultured in minimal 
essential medium (MEM), supplemented with 10% 
foetal calf serum (FCS), 1% antibiotic mixture (Pen/ 
Strep), and 1% nonessential aminoacids (NEAA). 
All media and supplements were obtained from 
Lonza Ltd. (Basel, Switzerland). The cells were 
cultured and expanded in standard conditions, at 
37°C and 5% CO2 atmosphere.  
MTT assay 
Cells where seeded onto a 96-well culture plate at a 
cellular density of 5,000 cells/well and attached to 
the bottom of the well during an overnight. After 24 
h, 100 µL of new medium containing the tested 
substances (dissolved in dimethyl sulfoxide - 
DMSO; purchased from Sigma-Aldrich Ltd., 
Budapest, Hungary) were added and incubated for 
72 h. The cells were then assayed by the addition of 
20 µL of 5 mg/mL MTT solution (purchased from 
Sigma-Aldrich Ltd., Budapest, Hungary). The intact 
mitochondrial reductase converted MTT into blue 
formazan crystals during a 4 h contact period and 
the precipitated crystals were dissolved in 100 µL 
DMSO. Finally, the reduced MTT was spectro-
photometrically analysed at 545 nm, using a Stat 
Fax microplate reader (Awareness Technology, Palm 
City, FL, USA); wells with untreated cells were 
considered as reference for viability. All in vitro 
experiments were carried out on two microplates in 
quadruplicates for each substance tested and controls. 
The DMSO concentration (0.3%) of the medium did 
not have any significant effect on cell proliferation. 
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In vitro antibacterial activity 
Rutin, its BCD complexes and the native CDs were 
tested for the antimicrobial activity using 11 strains: 
Bacillus cereus (ATCC 14579), Staphylococcus aureus 
(ATCC 25923), Streptococcus pyogenes (ATCC 
19615), Streptococcus pneumoniae (ATCC 49619), 
Enterococcus faecalis (ATCC 29212), Escherichia 
coli (ATCC 25922), Yersinia enterocolitica (ATCC 
23715), Klebsiella pneumoniae (ATCC 700603), 
Proteus mirabilis (ATCC 25933), Pseudomonas 
aeruginosa (ATCC 27853), Candida albicans (ATCC 
10231) by the diffusion method as previously described 
[27, 29]. The antibacterial and antimycotic activity 
were determinate according to the National Committee 
for Clinical Laboratory Standards (NCCLS, 1997). 
A microbial suspension with a concentration of 108 
CFU/mL was employed. The compounds were 
diluted in DMSO at a concentration of 10 mM. The 
inoculum was dispersed on the Mueller-Hinton agar 
plates and filter paper discs 6 mm in diameter 
impregnated with the solution of the tested 
compounds were distributed on the surface. Paper 
disks impregnated with BCD, HPBCD and RAMEB 
were also used. The native CDs did not have any 
effect on the selected strains. The plates were incubated 
at 37°C for 24 h. The inhibition zone diameters were 
determined with a ruler. Triplicate tests were performed 
and medium values are reported. For positive controls, 
discs with gentamicin or fluconazole were used, with 
inhibition zones between 16 - 19 mm. 
 
Results and Discussion 
Antiproliferative activity for the selected cell lines 
A2780, MDA-MB-231 and SiHa showed no substantial 
grow inhibition when treated with pure rutin and its 
CDs complexes at 30 µg/mL. In some cases a 
modest increase in cell viability was evidenced but 
no practical relevance can be attributed to this 




Antiproliferative activity of rutin and its cyclodextrin inclusion complexes against three tumor cell lines at 30 µg/mL 
 
The antimicrobial screening showed that rutin elicits 
antibacterial properties on some of the screened 
strains, namely S. pyogenes (19 mm), E. faecalis 
(19 mm), B. cereus (16 mm), P. aeruginosa (16 mm), 
K. pneumoniae (16 mm) and E. coli (16 mm). These 
strains present comparable inhibition zones with 
gentamicin, the positive control. A decreased but 
detectable activity was noticed for S. aureus (12 mm) 
and S. pneumoniae (11 mm). Incorporation in the 
ramified CDs had a mixt effect on the antibacterial 
activity. For S. pyogenes and E. faecalis, incorporation 
in each of the three CDs conduced to a decreased 
inhibition zone. For S. pneumoniae, B. cereus, P. 
aeruginosa, K. pneumoniae, and E. coli the activity 
was constant whereas for S. aureus the diameter of 
the inhibition zone increased from 12 mm for pure 
rutin to 17 mm for rutin:BCD and rutin:HPBCD, 
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Table I 
The antimicrobial activity of rutin and its CDs inclusion complexes (the values are presented as average of three 
determinations) 
Strains Rutin Rutin BCD Rutin HPBCD Rutin RAMEB 
E. coli  16 mm 16 mm 16 mm 16 mm 
Klebsiella pneumoniae 16 mm 16 mm 16 mm 16 mm 
Proteus mirabilis 6 mm 6 mm 6 mm 6 mm 
Yersinia enterocolitica 6 mm 6 mm 6 mm 6 mm 
Pseudomonas aeruginosa 16 mm 16 mm 16 mm 16 mm 
Bacillus cereus 16 mm 16 mm 16 mm 16 mm 
Streptococcus pneumoniae 11 mm 11 mm 11 mm 11 mm 
Streptococcus pyogenes 19 mm 13 mm 16 mm 15 mm 
Staphylococcus aureus  12 mm 17 mm 17 mm 16 mm 
Enterococcus faecalis 19 mm 15 mm 11 mm 12 mm 
 
In terms of natural compounds, flavonoids are one of 
the most studied class of phytochemicals for cancer 
chemoprevention [7]. Nano-encapsulation represents 
a method applied in order to enhance bioactivity 
and/or bioavailability of biologically active molecules. 
It was demonstrated that internal water molecules 
of CDs, are displaced by an increased number of 
hydrophobic compounds [30]. Ghasemzadeh et al 
evaluating the main bioactive compounds from 
curry leaf extracts (Murraya koenigii L) containing 
rutin in a concentration of 0.082 mg/g DW as per 
HPLC determination have shown that the extract 
presents antiproliferative properties against MDA-
MB-231 breast cancer cells. The biological effect 
was assigned to the phytocomplex [10]. It is very 
well known that rutin is the glycoside of quercetin, 
and although to the best of our knowledge rutin was 
not reported in the literature as an active agent on 
breast, ovarian and cervical cancer cells, quercetin 
was [32, 38, 40]. Correlated to our results, namely 
stimulation of proliferation for A2780 cell line, Luo 
et al have described that rutin hydrate stimulates 
the proliferation of OVCAR-3 ovarian cancer cells 
[20]. Nevertheless previous studies regarding the in 
vitro and in vivo anticancer properties of rutin 
depict that also this glycoside, not only the aglycone 
quercetin, acts as an active agent on other cancer 
cell lines hence our idea to screen its effect on 
A2780, MDA-MB-231 and SiHa cancer cell lines. 
Antiproliferative effects were also observed in case 
of HTC hepatic cells, WEHI-3 murine leukaemia 
cells, SW480 human colon adenocarcinoma cells 
and recent papers published informations about its 
protective effect against induced oxidative stress 
and apoptosis in human lens epithelial cells as well 
as against the pro-carcinogenic agent benzo(a)pyrene 
[5, 18, 46]. Regarding the mechanism of action, rutin 
acts to various modulators of Wnt signalling. For 
example, the DNA doxorubicin induced damage 
was highly diminished when rutin was incubated 
with HepG2 human liver carcinoma cell line but 
some studies showed that rutin caused DNA 
damage on BRCA mutant breast cancer cells [21]. 
Chemo-preventive effects were detailed in case of 
animal model of colon cancer and other in vivo 
studies have shown the important effects of rutin in 
diminishing tumour growth in mice implanted with 
SW480 human colon adenocarcinoma, metastatic 
A549 human lung adenocarcinoma, LLC Lewis lung 
carcinoma and HL-60 human promyelocytic leukaemia 
[16, 43]. Although active on above mentioned cell 
lines, rutin showed an overall poor antiproliferative 
activity against cell lines tested in the present study 
A2780, MDA-MB-231 and SiHa. Increased dissolution 
and absorption of rutin may be achieved by 
complexation with CDs. Paczkowska et al have 
demonstrated that inclusion of rutin in CDs leads to 
increased chemical solubility, stability, dissolvability 
and antibacterial activity for some of the selected 
strains [28]. The antiproliferative effects of rutin 
proved to be unsubstantial on the selected cell lines 
which were not changed when it was applied as CD 
complexes (Figure 1). Some studies have described 
that the inclusion complex of rutin with HPBCD 
have been identified to have the highest stabilizing 
effect in aqueous solutions [24, 37]. The antimicrobial 
activity of rutin obtained as a methanolic extract from 
Pteris vittata L. was screened against eight intestinal 
microorganisms by the group of Singh et al. Disk 
diffusion and micro-dilution methods showed 
efficiency for P. aeruginosa and K. pneumoniae [34]. 
Also, aqueous extracts containing rutin from Castanea 
sativa Mill. leaves where analysed in terms of anti-
microbial activity against S. aureus, K. pneumoniae, 
P. aeruginosa, Proteus vulgaris, E. coli, Enterobacter 
cloacae, Salmonella typhi and Enterobacter aerogens. 
Minimum inhibitory concentrations where detected 
between 32 and 128 µg/mL [3]. In a similar study, 
Dubey et al, assessed the antimicrobial activity of 
rutin using concentrations ranging from 10 µg/mL 
to 0.05 µg/mL and reported positive results for S. 
aureus, E. coli, Klebsiella oxytoca, P. aeruginosa 
and Candida albicans [8]. As it can be seen from 
Table I the results of our screening corroborate with 
the ones presented by other studies in the field. The 
novelty that comes with this study is the analyse of 
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the antimicrobial activity after incorporation in 
CDs. Wang et al have showed an increased anti-
bacterial potency for miconazole after incorporation 
into a cellulosic fabric grafted with BCD [41]. Sun 
et al have shown that chitosan films containing 
BCD and essential oils have increased the anti-
infective properties of the chitosan films, while 
Iacovino et al have concluded that the antibacterial 
activity of pipemidic acid is increased for some of 
the tested strains after incorporation in BCD [14, 
39]. In a recent study, Corciova et al. proven that 
complexation of hesperidin with BCD led to higher 
antibacterial and antioxidant effect [4]. On the other 
hand, Zhao et al, analysing BCD inclusion complex 
of chlorogenic acid, concluded that in terms of 
antioxidant and antibacterial capacity no significant 
difference was observed between the pure substance 
and the inclusion complex [45]. As depicted in the 
results section, in this study the majority of the 
tested strains acted in the same manner after 
incorporation took place. Only in case of S. aureus 
the potency was increased.  
 
Conclusions 
Rutin can be re-considerate as a natural active 
antibacterial agent against S. pyogenes, E. faecalis, 
B. cereus, P. aeruginosa, K. pneumoniae and E. 
coli. Modulation of the solubility by incorporation in 
CDs is debatable depending on the tested strain. On the 
other hand, both the glycoside and its CDs inclusion 
complexes elicited no substantial antiproliferative 
effect against A2780 human ovarian, MDA-MB-231 
human breast and SiHa cervical cancer cell lines at 
a relatively high final concentration. 
 
Acknowledgement 
Authors thank Péter Bérdi for his excellent assistance 
in the cell based assays. 
 
References 
1. Amin MU, Khurram M, Khattak B, Khan J, 
Antibiotic additive and synergistic action of rutin, 
morin and quercetin against methicillin resistant 
Staphylococcus aureus. BMC Complement Altern 
Med., 2015; 15(1): 1-12.  
2. Azzi J, Danjou PE, Landy D, Ruellan S, Auezova 
L, Greige-Gerges H, Fourmentin S, The effect of 
cyclodextrin complexation on the solubility and 
photostability of nerolidol as pure compound and as 
main constituent of cabreuva essential oil. Beilstein 
J Org Chem., 2017; 13: 835-844.  
3. Basile A, Sorbo S, Giordano S, Ricciardi L, Ferrara 
S, Montesano D, Castaldo Cobianchi R, Vuotto ML, 
Ferrara L, Antibacterial and allelopathic activity of 
extract from Castanea sativa leaves. Fitoterapia, 
2000; 71(Suppl.1): S110-S116. 
4. Corciova A, Ciobanu C, Poiata A, Mircea C, 
Nicolescu A, Drobota M,  Varganici CD, Pinteala T, 
Marangoci N, Antibacterial and antioxidant properties 
of hesperidin:β-cyclodextrin complexes obtained by 
different techniques. J Incl Phenom Macrocycl Chem., 
2015; 81(1-2): 71-84. 
5. Cristina Marcarini J, Ferreira Tsuboy MS, Cabral Luiz 
R, Regina Ribeiro L, Beatriz Hoffmann-Campo C, 
Ségio Mantovani M, Investigation of cytotoxic, 
apoptosis-inducing, genotoxic and protective effects 
of the flavonoid rutin in HTC hepatic cells. Exp Toxicol 
Pathol., 2011; 63(5): 459-465. 
6. Danciu C, Bojin F, Ambrus R, Muntean D, Soica 
C, Paunescu V, Cristea M, Pinzaru I, Dehelean C, 
Physico-chemical and biological evaluation of flavonols: 
fisetin, quercetin and kaempferol alone and incorporated 
in beta cyclodextrins. Anticancer Agents Med Chem., 
2016; 17(4): 615-626. 
7. Danciu C, Citu C, Zupko I, Ghiulai R, Matusz P, 
Pavel IZ, Popescu A, Pinzaru I, Simu G, Vlad CD, 
In vitro antiproliferative activity of flavonols: Fisetin, 
quercetin and kaempferol and their cyclodextrin 
complexes. Farmacia, 2015; 63(6): 858-864. 
8. Dubey S, Ganeshpurkar A, Bansal D, Dubey N, 
Experimental studies on bioactive potential of rutin. 
Chronicles of Young Scientists, 2013; 4(2): 153-157. 
9. Filip C, Albu E, Lupașcu D, Filip N, The influence 
of a new rutin derivative in an experimental model of 
induced hyperhomocysteinemia in rats. Farmacia, 
2017; 65(4): 596-599.  
10. Ghasemzadeh A, Jaafar HZE., Rahmat A., 
Devarajan T, Evaluation of bioactive compounds, 
pharmaceutical quality, and anticancer activity of 
curry leaf (Murraya koenigii L.). Evid Based 
Complement Alternat Med., 2014; 2014: 1-8. 
11. Han X, Xue X, Zhao Y, Li Y, Liu W, Zhang J, Fan 
S, Rutin-enriched extract from Coriandrum sativum L. 
ameliorates ionizing radiation-induced hematopoietic 
injury. Int J Mol Sci., 2017; 18(5): 1-20. 
12. Heghes A, Hadaruga NG, Fulias AV, Bandur GN, 
Hadaruga DI, Dehelean CA, Capsicum annuum 
extracts/beta-cyclodextrin complexes Thermal 
analyses-Karl Fischer water titration correlations 
and antioxidant activity. J Therm Anal Calorim., 
2015; 120(1): 603-615. 
13. Ho G, Wangensteen H, Barsett H, Elderberry and 
elderflower extracts, phenolic compounds, and 
metabolites and their effect on complement, RAW 
264.7 macrophages and dendritic cells. Int J Mol 
Sci., 2017; 18(3): 1-17.  
14. Iacovino R, Rapuano F, Caso JV, Russo A, 
Lavorgna M, Russo C, Isidori M, Russo L, 
Malgieri G, Isernia C, β-Cyclodextrin Inclusion 
Complex to Improve Physicochemical Properties of 
Pipemidic Acid: Characterization and Bioactivity 
Evaluation. Int J Mol Sci., 2013; 14(7): 13022-13041. 
15. Ihme N, Kiesewetter H, Jung F, Hoffmann KH, Birk 
A, Müller A, Grützner KI, Leg oedema protection 
from a buckwheat herb tea in patients with chronic 
venous insufficiency: A single-centre, randomised, 
double-blind, placebo controlled clinical trial. Eur J Clin 
Pharmacol., 1996; 50(6): 443-447. 
16. Kahali B, Marquez SB, Thompson KW, Yu J, 
Gramling SJ, Lu L, Aponick A, Reisman D, 
Flavonoids from each of the six structural groups 
reactivate BRM, a possible cofactor for the 
FARMACIA, 2018, Vol. 66, 2 
 307 
anticancer effects of flavonoids. Carcinogenesis, 
2014; 35(10): 2183-2193. 
17. Kreft I, Fabjan N, Yasumoto K, Rutin content in 
buckwheat (Fagopyrum esculentum Moench) food 
materials and products. Food Chem., 2006; 98(3): 
508-512. 
18. Lin JP, Yang JS, Lu CC, Chiang JH, Wu CL, Lin 
JJ, Lin HL, Yang MD, Liu KC, Chiu TH, Chung 
JG, Rutin inhibits the proliferation of murine 
leukemia WEHI-3 cells in vivo and promotes immune 
response in vivo. Leuk Res., 2009; 33(6): 823-828. 
19. Liu JL, Li LY, He GH, Optimization of microwave-
assisted extraction conditions for five major bioactive 
compounds from flos sophorae immaturus 
(Cultivars of Sophora japonica L.) using response 
surface methodology. Molecules, 2016; 21(3): 1-27.  
20. Luo H, Jiang BH, King SM, Chen YC, Inhibition of cell 
growth and VEGF expression in ovarian cancer cells by 
flavonoids. Nutr Cancer., 2008; 60(6): 800-809. 
21. Maeda J, Roybal EJ, Brents CA, Uesaka M, Aizawa 
Y, Kato TA Natural and glucosyl flavonoids inhibit 
poly(ADP-ribose) polymerase activity and induce 
synthetic lethality in BRCA mutant cells. Oncol 
Rep., 2014; 31(2): 551-556. 
22. Mancuso G, Borgonovo G, Scaglioni L, Bassoli A, 
Phytochemicals from Ruta graveolens activate 
TAS2R bitter taste receptors and TRP channels 
involved in gustation and nociception. Molecules, 
2015; 20(10): 18907-18922.  
23. Nassiri-Asl M, Adineh M, Hajiali F, Nassiri-Asl M, 
Treatment with rutin - A therapeutic strategy for 
neutrophil-mediated inflammatory and autoimmune 
diseases. J Pharmacopuncture, 2017; 20(1): 52-56.  
24. Nguyen TA, Liu B, Zhao J, Thomas DS, Hook JM, 
An investigation into the supramolecular structure, 
solubility, stability and antioxidant activity of 
rutin/cyclodextrin inclusion complex. Food Chem., 
2013; 136(1): 186-192. 
25. Oliveira VM, Carraro E, Auler ME, Khalil NM, 
Quercetin and rutin as potential agents antifungal 
against Cryptococcus spp. Braz J Biol., 2016; 
76(4): 1029-1034.  
26. Oprean C, Mioc M, Csányi E, Ambrus R, Bojin F, 
Tatu C, Cristea M, Ivan A, Danciu C, Dehelean C, 
Paunescu V, Soica C, Improvement of ursolic and 
oleanolic acids’ antitumor activity by complexation 
with hydrophilic cyclodextrins. Biomed Pharmacother., 
2016; 83: 1095-1104.  
27. Oprean C, Zambori C, Borcan F, Soica C, Zupko I, 
Minorics R, Bojin F, Ambrus R, Muntean D, 
Danciu C, Pinzaru IA, Dehelean C, Paunescu V, 
Tanasie G, Anti-proliferative and antibacterial in 
vitro evaluation of the polyurethane nanostructures 
incorporating pentacyclic triterpenes. Pharm Biol., 
2016; 54(11): 2714-2722 
28. Paczkowska M, Mizera M, Piotrowska H, 
Szymanowska-Powałowska D, Lewandowska K, 
Goscianska J, Pietrzak R, Bednarski W, Majka Z, 
Cielecka-Piontek J, Complex of rutin with β-
cyclodextrin as potential delivery system. PLoS 
One 2015, 10(3): 1-16. 
29. Pavel IZ, Danciu C, Oprean C, Dehelean CA, 
Muntean D, Csuk R, Muntean DM, In vitro 
evaluation of the antimicrobial ability and 
cytotoxicity on two melanoma cell lines of a 
benzylamide derivative of maslinic acid. Analytical 
Cellular Pathology, 2016; 2016: 1-6.  
30. Pinzaru I, Hadaruga DI, Hadaruga NG, Corpas L, 
Grozescu I, Peter F, Hepatoprotective flavonoid 
bioconjugate/beta-cyclodextrin nanoparticles: DSC 
- molecular modeling correlation. Dig J Nanomater 
Biostruct., 2011; 6(4): 1605-1617. 
31. Pinzaru I, Trandafirescu C, Szabadai Z, Mioc M, 
Ledeti I, Coricovac D, Ciurlea S, Ghiulai RM, 
Crainiceanu Z, Simu G, Synthesis and biological 
evaluation of some pentacyclic lupane triterpenoid 
esters. Rev Chim., 2014; 65(7): 848-851. 
32. Ren MX, Deng XH, Ai F, Yuan GY, Song HY, 
Effect of quercetin on the proliferation of the 
human ovarian cancer cell line SKOV-3 in vitro. 
Exp Ther Med., 2015; 10(2): 579-583. 
33. Santos BL, Silva AR, Pitanga BP, Sousa CS, 
Grangeiro MS, Fragomeni BO Coelho PL, Oliveira 
MN, Menezes-Filho NJ, Costa MF, El-Bachá RS, 
Velozo ES, Sampaio GP, Freire SM, Tardy M, Costa 
SL, Antiproliferative, proapoptotic and morphogenic 
effects of the flavonoid rutin on human glioblastoma 
cells. Food Chem., 2011; 127(2): 404-411.  
34. Singh M, Govindarajan R, Rawat AKS, Khare PB, 
Antimicrobial flavonoid rutin from Pteris vittata L. 
against pathogenic gastrointestinal microflora. 
American Fern Journal., 2008; 98(2): 98-103. 
35. Singh UP, Singh NP, Busbee B, Guan H, Singh B, 
Price RL, Taub DD, Mishra MK, Nagarkatti M, 
Nagarkatti PS, Alternative medicines as emerging 
therapies for inflammatory bowel diseases. Int Rev 
Immunol., 2012; 31(1): 66-84.  
36. Soica C, Coricovac D, Dehelean C1, Pinzaru I, 
Mioc M, Danciu C, Fulias A, Puiu M, Sitaru C, 
Nanocarriers as tools in delivering active compounds 
for immune system related pathologies. Rec Pat 
Nanotechnol., 2016; 10(2): 128-145. 
37. Sri KV, Kondaiah A, Ratna JV, Annapurna A, 
Preparation and characterization of quercetin and 
rutin cyclodextrin inclusion complexes. Drug Dev 
Ind Pharm., 2007; 33(3): 245-253. 
38. Srivastava S, Somasagara RR, Hegde M, Nishana 
M, Tadi SK, Srivastava M, Choudhary B, 
Raghavan SC, Quercetin, a natural flavonoid 
interacts with dna, arrests cell cycle and causes 
tumor regression by activating mitochondrial 
pathway of apoptosis. Sci Rep., 2016; 6: 1-13. 
39. Sun X, Sui S, Ference C, Zhang Y, Sun S, Zhou N, 
Zhu W, Zhou K, Antimicrobial and mechanical 
properties of β-cyclodextrin inclusion with essential 
oils in chitosan films. J Agric Food Chem., 2014; 
62(35): 8914-8918. 
40. Vidya Priyadarsini R, Senthil Murugan R, Maitreyi 
S, Ramalingam K, Karunagaran D, Nagini S, The 
flavonoid quercetin induces cell cycle arrest and 
mitochondria-mediated apoptosis in human cervical 
cancer (HeLa) cells through p53 induction and NF-
κB inhibition. Eur J Pharmacol., 2010; 649(1-3): 
84-91. 
41. Wang J, Cai Z, Incorporation of the antibacterial 
agent, miconazole nitrate into a cellulosic fabric 
grafted with β-cyclodextrin. Carbohydr Polym., 
2008; 72(4): 695-700. 
FARMACIA, 2018, Vol. 66, 2 
 308 
42. Xu DP, Zheng J, Zhou Y, Li Y, Li S, Li HB, 
Extraction of natural antioxidants from the 
Thelephora ganbajun mushroom by an ultrasound-
assisted extraction technique and evaluation of 
antiproliferative activity of the extract against 
human cancer cells. Int J Mol Sci., 2016; 17(10):1-15. 
43. Yang J, Guo J, Yuan J, In vitro antioxidant 
properties of rutin. LWT - Food Sci Technol., 2008; 
41(6): 1060-1066.  
44. Yang K, Lamprecht SA, Liu Y, Shinozaki H, Fan K, 
Leung D, Newmark H, Steele VE, Kelloff GJ, Lipkin 
M, Chemoprevention studies of the flavonoids quercetin 
and rutin in normal and azoxymethane-treated 
mouse colon. Carcinogenesis, 2000; 21(9): 1655-1660. 
45. Zhao M, Wang H, Yang B, Tao H, Identification of 
cyclodextrin inclusion complex of chlorogenic acid 
and its antimicrobial activity. Food Chem., 2010; 
120(4): 1138-1142. 
46. Zhou YF, Guo B, Ye MJ, Liao RF, Li SL, 
Protective effect of rutin against H2O2-induced 
oxidative stress and apoptosis in human lens 
epithelial cells. Curr Eye Res., 2016; 41(7): 933-942. 
 
 
 
 
